Healthcare InnoMatch 2022

No, Start-ups/SMEs applying for Healthcare InnoMatch 2022 do not need to be incorporated within last five (5) years.

The Challenge will consider several factors, such as prior test bed result, early market data, number of sites of implementation, extent of adoption (if any). Solutions will preferably be at a high level of market readiness. (i.e. Technology Readiness Level 7 and beyond, Healthcare Translational Level 3 and beyond, or the equivalent).

The winners will be selected based on how well the solutions can meet healthcare needs. There will be up to three (3) winners selected at the end of the Challenge.

The project agreement would be between one healthcare cluster and one Start-up or SME [up to three (3) matched pairs]. However, if the solution is co-developed with another start-up partner, but being submitted under one start-up, it will be accepted in the Challenge.

In the application stage, you are required to indicate an estimated cost. If you are shortlisted or selected as the final winner, more clarification and discussion will ensue with the reviewing panel and partner institution.

There are no restrictions for that. It would be good to have a mixture of both, so that the organisers may understand the background of your company, business proposition, and the solution. It is not mandatory for you to submit a video but highly encouraged as it will help the panel engage with your project team.

Yes, it is possible, with more than one solution.

Yes, regardless of its business area, locally or overseas, Start-up/SMEs with revenues below Singapore Dollars One Hundred Million ($100,000,000) can participate in the Challenge. This may include research institutions and innovation units of enterprises, if they are subsidiaries.

Similar to many developed nations, Singapore experiences a rapidly aging population, with similar healthcare issues such as elderly population with decreasing function and increasing need for home care services. Healthcare institutions often collaborate with community partners to delivery such care. Healthcare InnoMatch is open to any submission that targets improving care for the elderly, but I will be assessed by the participating partner healthcare cluster on how well the solution falls within their plan for population health.

The healthcare concerns in Singapore are similar to many developed nations. Solutions submitted may not necessary be for these issues only. There are other issues such as mental health, aging and frailty etc. More importantly is for participants to demonstrate where the solutions had been validated and its value proposition.

The theme seeks broadly for digital solutions to improve patient journey and experience, and it will consider salutations other than the consultation.

The solution may encompass the following and need not to be just for patients in hospitals:

• Bridge the gap between hospital and home/community (both upstream and downstream)
• Provide timely intervention to monitor and manage patients remotely
• Deliver solutions for preventive and predictive care, transition of care, and patient activation for better self-management of care for patient and care takers

The aim of the test-bedding phase is to demonstrate if the solution would be feasible in a real world, operating Healthcare Institution environment in Singapore. The test bedding should be designed to inform of potential adoption. Winners will have the opportunity to discuss and refine the success criteria of the test bedding project with the partner hospital before commencing the project.

The test bedding project should be designed to demonstrate the feasibility and viability in operational environments. The results should be significant for the healthcare cluster to make a decision on whether to adopt and procure the solutions after the test-bedding.

The specifics will be at the discretion of the participants in discussion with the eventual partner healthcare cluster. There will be specific department(s) who would be potential users in the healthcare cluster for the solution. The winning teams will be given two (2) months to discuss with the partner healthcare cluster on how to refine the test-bedding project.

There will be a principal investigator at the test-bedding site in the partner healthcare cluster to oversee the project. The hospital stakeholders/research offices will look at how the solutions will be used for/on the patients or staff.

No. The healthcare institutions for testbed would only be from the participating healthcare clusters for this specific challenge. The participating healthcare clusters are SingHealth Services (SHS), National University Health System (NUHS) and National Healthcare Group (NHG) only.

No, the project agreement and funding will be between one (1) start-up/SME and one healthcare cluster only. It cannot be used for the test-bedding with the other institutions. However, you may note that the evaluation outcomes of the solution will be shared with the other healthcare clusters under the three (3) partner healthcare clusters, which will inform the healthcare cluster on the decision to adopt and procure the solution.

Broadly speaking, there should not be access to discrete data. But you may discuss this with the partner healthcare cluster as to what data is needed to carry out a meaningful test bedding project. All prevailing data privacy practices would have to be adhered to.

This will be at the discretion of the partner healthcare cluster and their respective IT offices, who will advise on the best and/or encouraged practices.

Direct costs:

• To cover costs directly associated with proof-of-value/test bedding project, such as pilot manufacture, purchase of consumables, customisation, test-bedding services (such as protocol planning, test bed execution and data management), analytics and evaluation services.
• Evaluation Services must be performed by the partner hospital. The partner hospital may engage an independent expert for the purpose of evaluating the proof-of-value/test bedding project at their discretion. Participants are to provide an estimation for evaluation for the purposes of submission based on best knowledge.

No. The principal investigator will be from the assigned partner healthcare cluster.

CHISEL Project funding is equity-free, non-dilutive and non-debt.

All test bedding projects will have to be performed in accordance to local and hospital regulations and guidelines. Depending on the solution, some projects will need to engage the local IT agency for public healthcare, which will be done with the partner hospital’s IT offices.

Yes, it will be sufficient for the test-bed. The Healthcare InnoMatch also hopes that through this platform, it may help value add and accelerate approvals in Singapore subsequently. If the solution is already in the process of obtaining HSA’s clearance, it will be good to submit as well.

The intent of Healthcare InnoMatch is not to co-create or co-develop solutions. Hence there will not be much opportunity for foreground IP creation. Most of the IP will reside with the company as background IP. However, if there are opportunities for publications, the start-up/SME can further discuss this with the partner healthcare cluster.